Neuralink registers PRIME2 trial for N1 R1

Neuralink has registered PRIME2, a new brain implant trial designed for adults with lasting arm and hand paralysis caused by strokes, spinal cord injuries, or ALS. The study will test the company's N1 brain implant and R1 surgical robot to evaluate whether participants can control a computer cursor and type using only their thoughts. Enrollment is currently open for up to 10 adults, with the University of Miami listed as a recruiting site. Open article →